David Q. Shih,Stephan R. Targan,Dalin Li,Janine Bilsborough
申请号：
US16798030
公开号：
US20200190203A1
申请日:
2020.02.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to methods of treating fibrosis and inflammatory bowel disease. In one embodiment, the present invention treats gut inflammation by administering a therapeutically effective dosage of TL1A inhibitors and/or DR3 inhibitors to an individual. In another embodiment, the present invention provides a method of reversing tissue fibrosis in an individual by inhibiting TL1A-DR3 signaling function.
